1. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA
Cancer J Clin. 2023;73(1):17-48. doi:10.3322/caac.21763
2. Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl
J Med. 2014;371(22):2140-2141. doi:10.1056/NEJMc1412266
3. Sivan A, Corrales L, Hubert N, et al. Commensal Bifidobacterium
promotes antitumor immunity and facilitates anti-PD-L1 efficacy.
Science. 2015;350(6264):1084-1089. doi:10.1126/science.aac4255
4. Vetizou M, Pitt JM, Daillere R, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science.
2015;350(6264):1079-1084. doi:10.1126/science.aad1329
5. Gopalakrishnan V, Spencer CN, Nezi L, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.
Science. 2018;359(6371):97-103. doi:10.1126/science.aan4236
6. Matson V, Fessler J, Bao R, et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.
Science. 2018;359(6371):104-108. doi:10.1126/science.aao3290
7. Routy B, Le Chatelier E, Derosa L, et al. Gut microbiome influences
efficacy of PD-1-based immunotherapy against epithelial tumors.
Science. 2018;359(6371):91-97. doi:10.1126/science.aan3706
8. Poore GD, Kopylova E, Zhu Q, et al. Microbiome analyses of
blood and tissues suggest cancer diagnostic approach. Nature.
2020;579(7800):567-574. doi:10.1038/s41586-020-2095-1
9. Castellarin M, Warren RL, Freeman JD, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome
Res. 2012;22(2):299-3 06. doi:10.1101/gr.126516.111
10. Nomoto D, Baba Y, Liu Y, et al. Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the
NOD1/RIPK2/NF-kappa B pathway. Cancer Lett. 2022;530:59-67.
doi:10.1016/j.canlet.2022.01.014
11. Yamamura K, Baba Y, Miyake K, et al. Fusobacterium nucleatum
in gastroenterological cancer: evaluation of measurement methods
using quantitative polymerase chain reaction and a literature review. Oncol Lett. 2017;14(6):6373-6378. doi:10.3892/ol.2017.7001
12. Xuan C, Shamonki JM, Chung A, et al. Microbial dysbiosis is associated with human breast cancer. PLoS One. 2014;9(1):e83744.
doi:10.1371/journal.pone.0083744
13. Urbaniak C, Gloor GB, Brackstone M, Scott L, Tangney M, Reid G.
The microbiota of breast tissue and its association with breast cancer. Appl Environ Microbiol. 2016;82(16):5039-5048. doi:10.1128/
aem.01235-16
13497006, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/cas.15901 by Cochrane Japan, Wiley Online Library on [14/07/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
12 14. Riquelme E, Zhang Y, Zhang L, et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell.
2019;178(4):795-8 06.e12. doi:10.1016/j.cell.2019.07.008
15. Pushalkar S, Hundeyin M, Daley D, et al. The pancreatic cancer
microbiome promotes oncogenesis by induction of innate and
adaptive immune suppression. Cancer Discov. 2018;8(4):403-416.
doi:10.1158/2159-8290.Cd-17-1134
16. Geller LT, Barzily-Rokni M, Danino T, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357(6356):1156-1160.
doi:10.1126/science.aah5043
17. Mitsuhashi K, Nosho K, Sukawa Y, et al. Association of
Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget. 2015;6(9):7209-7220.
doi:10.18632/oncotarget.3109
18. Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium
nucleatum promotes colorectal carcinogenesis by modulating E-
cadherin/beta-c atenin signaling via its FadA Adhesin. Cell Host
Microbe. 2013;14(2):195-206. doi:10.1016/j.chom.2013.07.012
19. Yang Y, Weng W, Peng J, et al. Fusobacterium nucleatum increases
proliferation of colorectal cancer cells and tumor development in mice
by activating toll-like receptor 4 signaling to nuclear factor-kappa
B, and up-regulating expression of MicroRNA-21. Gastroenterology.
2017;152(4):851-866.e24. doi:10.1053/j.gastro.2016.11.018
20. Lamont RJ, Chan A, Belton CM, Izutsu KT, Vasel D, Weinberg A.
PORPHYROMONAS-GINGIVALIS invasion of gingival epithelial-
cells. Infect Immun. 1995;63(10):3878-3885. doi:10.1128/
iai.63.10.3878-3885.1995
21. Ohuchida K, Mizumoto K, Murakami M, et al. Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells
through tumor-stromal interactions. Cancer Res. 2004;64(9):3215-
3222. doi:10.1158/0008-5472.Can-03-2464
22. Kibe S, Ohuchida K, Ando Y, et al. Cancer-associated acinar-to-
ductal metaplasia within the invasive front of pancreatic cancer contributes to local invasion. Cancer Lett. 2019;444:70-81.
doi:10.1016/j.canlet.2018.12.005
23. Okumura T, Ohuchida K, Kibe S, et al. Adipose tissue-derived
stromal cells are sources of cancer-associated fibroblasts and enhance tumor progression by dense collagen matrix. Int J Cancer.
2019;144(6):1401-1413. doi:10.1002/ijc.31775
24. Okumura T, Ohuchida K, Sada M, et al. Extra-pancreatic invasion
induces lipolytic and fibrotic changes in the adipose microenvironment, with released fatty acids enhancing the invasiveness
of pancreatic cancer cells. Oncotarget. 2017;8(11):18280-18295.
doi:10.18632/oncotarget.15430
25. Sun X, He X, Zhang Y, et al. Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-
hijacked cancer escape mechanism. Gut. 2022;71(1):129-147.
doi:10.1136/gutjnl-2020-322744
26. Zhang QF, Ma C, Duan Y, et al. Gut microbiome directs hepatocytes
to recruit MDSCs and promote cholangiocarcinoma. Cancer Discov.
2021;11(5):1248-1267. doi:10.1158/2159-8290.Cd-20-0304
27. Raetz CRH, Whitfield C. Lipopolysaccharide endotoxins.
Annu Rev Biochem. 2002;71:635-700. doi:10.1146/annurev.
biochem.71.110601.135414
28. Miyamoto M, Shimizu Y, Okada K, Kashii Y, Higuchi K, Watanabe
A. Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer
cells. Cancer Immunol Immunother. 1998;47(1):47-57. doi:10.1007/
s002620050503
29. Wang B, Hendricks DT, Wamunyokoli F, Parker MI. A growth-
related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer. Cancer Res.
2006;66(6):3071-3 077. doi:10.1158/0008-5472.Can-05-2871
3 0. Tang ZF, Li CW, Kang BX, Gao G, Li C, Zhang Z. GEPIA: a web server
for cancer and normal gene expression profiling and interactive
31. 32. 33. 3 4. 35. 36. 37. 38. 39. 4 0. 41. 42. analyses. Nucleic Acids Res. 2017;45(W1):W98-W102. doi:10.1093/
nar/gkx247
Asfaha S, Dubeykovskiy AN, Tomita H, et al. Mice that express
human Interleukin-8 have increased mobilization of immature
myeloid cells, which exacerbates inflammation and accelerates
colon carcinogenesis. Gastroenterology. 2013;144(1):155-166.
doi:10.1053/j.gastro.2012.09.057
Nejman D, Livyatan I, Fuks G, et al. The human tumor microbiome
is composed of tumor type-specific intracellular bacteria. Science.
2020;368(6494):973-980. doi:10.1126/science.aay9189
Udayasuryan B, Ahmad RN, Nguyen TTD, et al. Fusobacterium
nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signaling. Sci Signal.
2022;15(756):eabn4948. doi:10.1126/scisignal.abn4948
Highfill SL, Cui YZ, Giles AJ, et al. Disruption of CXCR2-mediated
MDSC tumor trafficking enhances anti-PD1 efficacy. Sci Transl Med.
2014;6(237):237ra67. doi:10.1126/scitranslmed.3007974
Kuo P-L , Shen K-H, Hung S-H, Hsu YL. CXCL1/GRO alpha increases
cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-kappa B/HDAC1 epigenetic regulation.
Carcinogenesis. 2012;33(12):2477-2487. doi:10.1093/carcin/bgs299
Steele CW, Karim SA, Leach JDG, et al. CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in
pancreatic ductal adenocarcinoma. Cancer Cell. 2016;29(6):832-
845. doi:10.1016/j.ccell.2016.04.014
Fitzpatrick SG, Katz J. The association between periodontal disease
and cancer: a review of the literature. J Dent. 2010;38(2):83-95.
doi:10.1016/j.jdent.2009.10.007
Mohanty R, Asopa SJ, Joseph MD, et al. Red complex: polymicrobial conglomerate in oral flora: a review. J Family Med Primary Care.
2019;8(11):3480-3 486. doi:10.4103/jfmpc.jfmpc_759_19
Gnanasekaran J, Gallimidi AB, Saba E, et al. Intracellular
Porphyromonas gingivalis promotes the tumorigenic behavior of
pancreatic carcinoma cells. Cancers (Basel). 2020;12(8):2331.
doi:10.3390/cancers12082331
Tan Q, Ma X, Yang B, et al. Periodontitis pathogen Porphyromonas
gingivalis promotes pancreatic tumorigenesis via neutrophil elastase from tumor-associated neutrophils. Gut Microbes. 2022;14(1).
doi:10.1080/19490976.2022.2073785
Fan XZ, Alekseyenko AV, Wu J, et al. Human oral microbiome
and prospective risk for pancreatic cancer: a population-based
nested case-control study. Gut. 2018;67(1):120-127. doi:10.1136/
gutjnl-2016-312580
Naito M, Hirakawa H, Yamashita A, et al. Determination of the genome sequence of Porphyromonas gingivalis strain ATCC 33277 and
genomic comparison with strain W83 revealed extensive genome
rearrangements in P-gingivalis. DNA Res. 2008;15(4):215-225.
doi:10.1093/dnares/dsn013
S U P P O R T I N G I N FO R M AT I O N
Additional supporting information can be found online in the
Supporting Information section at the end of this article.
How to cite this article: Hayashi M, Ikenaga N, Nakata K,
et al. Intratumor Fusobacterium nucleatum promotes the
progression of pancreatic cancer via the CXCL1-CXCR2 axis.
Cancer Sci. 2023;00:1-13. doi:10.1111/cas.15901
13497006, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/cas.15901 by Cochrane Japan, Wiley Online Library on [14/07/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
13
HAYASHI et al.
...
論文の公開元へ
